Article Figures & Data
Figures
- Figure 1
- Receiver operating characteristic curve analysis of coronavirus disease-19 patients D-dimer. AUC: area under the curve
Tables
- Table 1
- Coronavirus disease-19 (COVID-19) and comparative subjects’ demographic data, symptoms, and end situation outcomes.
Variables COVID-19 Comparative subjects Gender Female 26 (23.2) 47 (41.9) Male 86 (76.8) 65 (58.1) Age (years) <30 5 (4.5) 18 (16.1) 30-60 74 (66.1) 45 (40.2) >60 33 (29.5) 49 (43.8) Mean±SD 51.66±15.3 54.96±18.6 Range 25-90 25-90 Nationality Saudi 66 (58.9) 73 (65.2) Egyptian 5 (4.5) 3 (2.7) Yemeni 13 (11.6) 10 (8.9) Pakistani and Filipina 8 (7.1) 9 (8) Bangladeshi 6 (5.4) 1 (0.9) Indian 4 (3.6) 2 (1.8) others 10 (8.9) 14 (12.5) Symptoms Mild and asymptomatic 45 (40.1) NA Moderate, severe, and critical 67 (59.9) NA Outcomes situation Recovered 86 (76.8) NA ICU patient 17 (15.2) NA Deceased 9 (8.0) NA Values are presented as a number and precentage (%). NA: not available, SD: standard deviation, ICU: intensive care unit
- Table 2
- Coronavirus disease-19 and comparative subjects’ coagulation parameters and platelets count results on admission.
Parameters COVID-19 Comparative subjects T-test P-values PT (seconds) 13.15±1.46 13.30±2.70 0.497 0.620 APTT (seconds) 33.69±5.42 30.63±7.47 3.47 <0.001* PLTs count (x103) 243.38±103.68 287.72±89.07 3.43 <0.001* D-dimer (μg/mL) 1.05±0.71 0.16±0.06 13.70 <0.001* INR 1.08±0.13 1.15±0.23 2.82 0.005* Values are presented as mean ± standard deviation (SD).
↵* Significant, PT: prothrombin time, APTT: activated partial thromboplastin clotting time, PLTs: mean platelets, INR: international normalized ratio
- Table 3
- Gender and age factors of the coronavirus disease -19 patient’s outcomes situation at the end of the study period (N=112).
Gender and age factors Outcomes situation χ2 P-values Recovered Non-recovered Gender Female 24 2 1.05 0.514 Male 73 13 Age >60 years old 23 10 9.85 <0.006* ≤60 years old 74 5 Values are presented as numbers. *Significant (Fisher exact test)
- Table 4
- Coronavirus disease-19 patient’s pattern of symptoms on admission and the outcomes of the patient’s situation concerning coagulation parameters and platelet count.
Parameters PT (seconds) aPTT (seconds) PLTs count (x103) D-dimer (μg/mL) INR Moderate, severe, and critical symptoms 13.44±1.5 33.82±5.96 243.02±109.89 1.29±0.82 1.09±0.14 Asymptomatic and mild symptoms 12.72±1.29 33.50±4.56 243.91±94.9 0.75±0.47 1.05±0.10 T-test (p-value) 3.19 (0.008)* 0.321 (0.749) 0.044 (0.956) 4.293 (<0.001)* 0.208 (0.110) ICU and deceased patients 13.54±2.03 34.22±6.58 219.78±108.00 1.47±0.75 1.10±0.19 Recovery patients 13.02±1.20 33.51±5.01 251.25±101.94 0.95±0.72 1.07±0.10 T-test (p-value) 1.63 (0.104) 0.601 (0.549) 1.39 (0.165) 3.32 (<0.001)* 1.07 (0.283) Values are presented as mean ± standard deviation (SD).
↵* Significant, PT: prothrombin time, aPTT: activated partial thromboplastin clotting time, PLTs: mean platelets, INR: international normalized ratio, ICU: intensive care unit
- Table 5
- Coagulation parameters and platelets count on admission assessment using binary logistic regression analysis
Coagulation parameters and platelets count B S.E. Exp(B) P-value D-dimer (μg/mL) 0.020 0.004 1.021 <0.001* PLTs count (x103) -0.006 0.005 .994 0.289 PT (seconds) -0.145 0.313 .865 0.643 INR -2.112 2.805 .121 0.451 APTT (seconds) 0.077 0.083 1.080 0.356 Constant -2.791 4.117 .061 0.498 ↵* Significant, PT: prothrombin time, APTT: activated partial thromboplastin clotting time, PLTs: mean platelets, INR: international normalized ratio
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.